Is autoimmune hepatitis on the rise?

Is autoimmune hepatitis on the rise?

By Craig Lammert, M.D., AIHA Executive Director One of the most common questions our members ask is “how common is AIH?” Unfortunately, it’s a challenging question, and the answer depends on which epidemiologic study you are reading. There is no doubt AIH is a...
An AIH Diagnosis During the Pandemic

An AIH Diagnosis During the Pandemic

Just as the COVID-19 pandemic was beginning in the United States in early 2020, Chicago-area resident Dave Richardson started to feel sluggish and tired all the time. He didn’t have much of an appetite and just didn’t feel like himself. His blood pressure ended up...
Research Update: ALT Levels in AIH

Research Update: ALT Levels in AIH

By Craig Lammert, M.D., AIHA Executive Director Currently, the most important treatment goal for autoimmune hepatitis (AIH) is normal liver tests (AST and ALT) and IgG levels. These numbers are used by treating doctors as surrogates for AIH-related liver inflammation....
Supporter Spotlight: Lisa Devereaux

Supporter Spotlight: Lisa Devereaux

Autoimmune Hepatitis Association (AIHA) Founding Member Lisa Devereaux has been a longtime supporter of the AIHA, from making monetary donations to volunteering countless hours connecting with other autoimmune hepatitis (AIH) patients. In this Q&A, she shares more...
All in the Family: An extra rare story

All in the Family: An extra rare story

By Erin AndersonAIHA Director of Programs and Advancement If having autoimmune disease were a competition, Lee Gipson (below left) jokes that she would take home the prize over her older sister, Jo McCoy (below right). Gipson has three autoimmune diseases, and McCoy...